Robinson, Andrew G.
Queen's University
3 papers on CoChatORCID 0000-0003-1152-4275
Most cited papers
- Verified
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer
Reck, M., Rodríguez-Abreu, D., Robinson, A. G., Hui, R., Csőszi, T., Fülöp, A., Gottfried, M., Peled, N., Tafreshi, A., Cuffe, S., et al. (2016) · New England Journal of Medicine
Cancer Immunotherapy and BiomarkersLung Cancer Treatments and Mutations
Cited by 10,089
- Verified
Updated analysis of KEYNOTE-024: pembrolizumab versus platinum-based chemotherapy for advanced non-small-cell lung cancer with PD-L1 tumor proportion score of 50% or greater
Reck, M., Rodríguez–Abreu, D., Robinson, A. G., Hui, R., Csőszi, T., Fülöp, A., Gottfried, M., Peled, N., Tafreshi, A., Cuffe, S., et al. (2019) · Journal of Clinical Oncology
Cancer Immunotherapy and BiomarkersLung Cancer Treatments and Mutations
Cited by 1,670
- Verified
Long-Term Mental Health Service Utilization Among Survivors of Testicular Cancer: A Population-Based Cohort Study
Raphael, M. J., Gupta, S., Wei, X., Peng, Y., Soares, C. N., Bedard, P. L., Siemens, D. R., Robinson, A. G., & Booth, C. M. (2021) · Journal of Clinical Oncology
Cancer survivorship and careChildhood Cancer Survivors' Quality of Life
Cited by 34
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free